Related references
Note: Only part of the references are listed.Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh et al.
CANCER RESEARCH (2014)
Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy
Ritika Jaini et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination
Oana Draghiciu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The Effect of the Anti-Angiogenic Drug Sunitinib Malate on the Vascular Architecture of Oral Squamous Cell Carcinoma
Vinicius Faccin Bampi et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2014)
Control of the immune response by pro-angiogenic factors
Thibault Voron et al.
FRONTIERS IN ONCOLOGY (2014)
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Cristina Iclozan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Ana M. Molina et al.
CLINICAL GENITOURINARY CANCER (2013)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Systemic Treatment Options for Untreated Patients With Metastatic Clear Cell Renal Cancer
Ana M. Molina et al.
SEMINARS IN ONCOLOGY (2013)
In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas
Olga Martinho et al.
TRANSLATIONAL ONCOLOGY (2013)
Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
Alexandra Sevko et al.
JOURNAL OF CANCER (2013)
S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways
Mohd W. Nasser et al.
CANCER RESEARCH (2012)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
iNOS-selective inhibitors for cancer prevention: promise and progress
Naveena B. Janakiram et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy
Benedetto Farsaci et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
Anabel Sorolla et al.
MOLECULAR ONCOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Minu K. Srivastava et al.
PLOS ONE (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system
Mateusz Walczak et al.
ANTIVIRAL THERAPY (2011)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model
Mengde Cao et al.
LABORATORY INVESTIGATION (2011)
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Jennifer S. Ko et al.
CANCER RESEARCH (2010)
Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors
Maria Sharmila A. Sousa et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens
Annechien J. A. Lambeck et al.
VACCINE (2010)
Molecular basis and management of gastrointestinal stromal tumors
Ulas D. Bayraktar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
Hong Xin et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells
Eliana Ribechini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues
Agnes Juhasz et al.
FREE RADICAL RESEARCH (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
Madeleine M. Hipp et al.
BLOOD (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice
Maciej Kujawski et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer
A. Riezebos-Brilman et al.
GENE THERAPY (2007)
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Sophie de Boueard et al.
NEURO-ONCOLOGY (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery
W. B. Lindsey et al.
CYTOTHERAPY (2007)
CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation
Qianli Meng et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248
Olga Potapova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
S Faivre et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor
AA Lugade et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-10 gene-deficient mice lack TGF-β/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis
PA Ruiz et al.
JOURNAL OF IMMUNOLOGY (2005)
Arginases I and II: do their functions overlap?
SD Cederbaum et al.
MOLECULAR GENETICS AND METABOLISM (2004)
c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model
M Kato et al.
CANCER RESEARCH (2004)
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
MJ Turk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine
YF He et al.
JOURNAL OF IMMUNOLOGY (2004)
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
